Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate
to Severe Ulcerative Colitis
Research Question:
Do the drug PF-06651600 or PF-06700841 treat ulcerative colitis.
Basic Study Information
Purpose:
Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting
inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects
the innermost lining of your large intestine (colon) and rectum. The purpose of this
study is to determine whether PF-06651600 and PF-06700841 are effective
in treatment of moderate to severe ulcerative colitis.
Location: University of Rochester Medical Center
Study Contact Information
Study Coordinator: Pfizer CT.gov Call Center
Email: ClinicalTrials.gov_Inquiries@pfizer.com
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search